- Home
- SDA vs PHAR Comparison
SDA vs PHAR Comparison
Compare SDA & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SDA
- PHAR
- Stock Information
- Founded
- SDA 2007
- PHAR 1988
- Country
- SDA China
- PHAR Netherlands
- Employees
- SDA N/A
- PHAR N/A
- Industry
- SDA Blank Checks
- PHAR Biotechnology: Pharmaceutical Preparations
- Sector
- SDA Finance
- PHAR Health Care
- Exchange
- SDA Nasdaq
- PHAR Nasdaq
- Market Cap
- SDA 548.5M
- PHAR 587.5M
- IPO Year
- SDA N/A
- PHAR N/A
- Fundamental
- Price
- SDA $2.86
- PHAR $8.61
- Analyst Decision
- SDA
- PHAR Strong Buy
- Analyst Count
- SDA 0
- PHAR 3
- Target Price
- SDA N/A
- PHAR $30.00
- AVG Volume (30 Days)
- SDA 183.3K
- PHAR 4.8K
- Earning Date
- SDA 04-28-2025
- PHAR 05-08-2025
- Dividend Yield
- SDA N/A
- PHAR N/A
- EPS Growth
- SDA N/A
- PHAR N/A
- EPS
- SDA N/A
- PHAR N/A
- Revenue
- SDA $425,992,000.00
- PHAR $297,200,000.00
- Revenue This Year
- SDA $63,167.77
- PHAR $8.26
- Revenue Next Year
- SDA N/A
- PHAR $9.73
- P/E Ratio
- SDA N/A
- PHAR N/A
- Revenue Growth
- SDA 29.36
- PHAR 21.15
- 52 Week Low
- SDA $2.41
- PHAR $6.65
- 52 Week High
- SDA $11.74
- PHAR $11.07
- Technical
- Relative Strength Index (RSI)
- SDA 29.32
- PHAR 55.96
- Support Level
- SDA $2.61
- PHAR $8.26
- Resistance Level
- SDA $2.98
- PHAR $8.84
- Average True Range (ATR)
- SDA 0.41
- PHAR 0.39
- MACD
- SDA 0.07
- PHAR 0.08
- Stochastic Oscillator
- SDA 38.66
- PHAR 82.44
About SDA SunCar Technology Group Inc.
SunCar Technology Group Inc is a provider of digitalized enterprise automotive after-sales services and online auto insurance intermediation service in China. It operates an automotive after-sales services business through offering customized service solutions to enterprise clients, who are major banks, insurance companies, telecommunication companies, new energy vehicle, original equipment manufacturers or any client who have end customers demanding automotive services.
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.